In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.
Magazine
We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs
The trial "Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults" has been published on Urologia Internationalis.
https://www.ncbi.nlm.nih.gov/pubmed/30889607
In the study, safety and efficacy of a Xyloglucan based medical device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated UTIs in adults.
New publication of a retrospective, observational study of Gelatin tannate versus other antidiarrheal medication in children with acute Gastroenteritis.
“A clinical trial recently published assessed the efficacy, safety and tolerability of a xyloglucan-based nasal spray (Rhinosectan) in the treatment of rhinosinusitis, and concluded that this medical device provided greater relief of symptoms than a physiological saline spray”. Allegrini A et al. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. Current Medical Research and Opinion, 2017. DOI: 0.1080/03007995.2017.1341402
